London: Scientists have used genome sequencing technology to control an outbreak of the superbug MRSA in a study that could point to faster and more efficient treatment of a range of diseases.

The $7.8-billion US-based medical technology major Becton Dickinson (BD), is in the final stages of developing a new technology for diagnosing tuberculosis (TB), which kills 300,000 Indians every y

A new imaging technique developed at the University of Oxford may be able to detect cancers that have spread to the brain even when tumours are small.

The alarming new trend of asking patients to undergo surgery they could do without

As science begins to solve the mystery of why heart attacks strike apparently healthy people without warning, Indian doctors keep in step with the new predictive theme of cardiac care.
Cardiologist Dr Ashok Seth keeps a photograph of Alok Tanwar in his office. It shows a robust young man, carefree, arms around his wife and daughters, laughing into the camera.

Any sufficiently advanced technology is indistinguishable from magic, Arthur C. Clarke once wrote. So it is with stem cells and their almost miraculous potential to save our lives. Stem cells are so tiny that it would take a million of them clustered together to form a pin head. Yet as their name denotes all other cells 'stem' from them.

Doctors, hospitals, drug makers and insurance companies will join President Obama on Monday in announcing their commitment to a sharp reduction in the growth of national health spending, White House officials said Sunday.

General Electric is shifting the strategy in its $17 billion-a-year health equipment and technology business, seeking to broaden its reach with more lower-cost products.

A television advertisement for a heart stent that promotes the product's potential benefits but seems to play down the medical risks may deceive the public and should be reviewed by federal regulators, according to a commentary in The New England Journal of Medicine. The 60-second ad for the Cypher stent, made by the Cordis subsidiary of Johnson & Johnson, fails to warn consumers adequately about the potential dangers of receiving a stent, two cardiologists argued in the essay, to appear in next Thursday's issue but already available online.